DALIAN, China -- Sinovac Biotech has begun manufacturing a coronavirus vaccine candidate on a pilot basis, as China shifts toward the mass production stage in the global immunization race.
Coronavirus
China's Sinovac starts production of COVID-19 vaccine candidate
Compatriot CanSino also rushes for mass output as clinical trials continue
Students in Indonesia wear protective face masks. Sinovac has agreed to supply 40 million doses to an Indonesian state-owned company. © Reuters
Read Next
Latest on Coronavirus
